Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2016

View Archived Issues

Asceneuron discloses glycosidase inhibitors

PharmaResearch Products and Lipopeptide establish strategic collaboration in wound care

Scientists report miRNAs that may be associated with mBCC

PsiOxus Therapeutics begins combination treatment in OCTAVE study

Gilead Sciences patents compounds to treat HIV

Han Wha Pharma and Yang Ji Chemical disclose JAK inhibitors

Prexton Therapeutics introduces mGlu4 receptor PAMs

Bristol-Myers Squibb describes HIV integrase inhibitors

University of Dayton reports antineoplastic and antibacterial compounds

AnaptysBio starts dosing in first-in-human phase I trial of ANB-020

Senhwa Biosciences enters agreement with CCTG for phase I/II study of CX-5461

Vericel releases topline results from phase IIb study of ixmyelocel-T

Phase III data show sarilumab superior to adalimumab in patients with active rheumatoid arthritis

FDA accepts for review Enbrel sBLA for pediatric chronic severe plaque psoriasis

Scancell and Karolinska Institutet collaborate to explore role of citrullination in cancer

Double-blind trial evaluates mexiletine in sporadic amyotrophic lateral sclerosis

SRI International awarded National Cancer Institute contract to develop cancer treatments

Bioresorbable sensors may enable wireless data collection in deep tissue and body cavities

Lundbeck initiates phase III program of Lu-AF-35700 for treatment-resistant schizophrenia

Enrollment under way in phase III trial of elafibranor for NASH

Novartis submits sBLA for ofatumumab with fludarabine and cyclophosphamide for relapsed CLL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...